查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855778

2025年全球體外診斷（IVD）人工智慧（AI）市場報告

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，體外診斷（IVD）領域的人工智慧（AI）市場發展迅猛，預計將從2024年的25.7億美元成長到2025年的30.4億美元，複合年成長率（CAGR）高達18.5%。推動這一成長的主要因素包括：熟練的醫療保健專業人員和放射科醫生短缺、政府和監管機構對基於人工智慧的診斷技術的支持力度不斷加大、人工智慧在基因組和分子診斷領域的應用日益廣泛、臨床醫生對人工智慧診斷準確性的認知不斷提高，以及雲端基礎的人工智慧診斷解決方案的日益廣泛。

預計未來幾年，體外診斷（IVD）領域的人工智慧（AI）市場將快速成長，到2029年市場規模將達到59.4億美元，複合年成長率（CAGR）為18.2%。預測期內的成長預計將受到以下因素的驅動：對快速準確診斷結果的需求不斷成長、慢性病和感染疾病的流行、對個人化和精準醫療日益成長的需求、對疾病早期檢測和預防的重視，以及由於電子健康記錄的廣泛應用而推動的醫療保健數位化進程。預測期內的主要趨勢包括：深度學習在病理學和診斷成像領域的進步、全自動高通量分析儀的創新、自然語言處理在診斷報告中的應用、人工智慧遠距離診斷平台的開發，以及人工智慧與穿戴式裝置和照護現場設備的整合。

體外診斷 (IVD) 中的人工智慧 (AI) 是指應用先進的演算法來分析從血液、組織、尿液和其他樣本的實驗室測試中獲得的醫學數據，從而實現更快、更準確、更數據主導的測試結果解釋，支持更早的疾病檢測、個性化治療決策和提高診斷效率。

體外診斷中人工智慧的主要組成部分包括軟體、硬體和服務。軟體由程式和資料構成，使電腦能夠執行特定任務。它利用機器學習、自然語言處理、電腦視覺、機器人流程自動化和深度學習等技術，並可以以雲端基礎、本地或混合模式部署。應用領域包括診斷影像、實驗室檢測、病理學、基因組學和個人化醫療。主要終端使用者包括醫院和診所、診斷實驗室、研究機構、製藥公司和醫療設備製造商。

美國關稅的快速上漲以及持續到2025年春季的貿易摩擦，對醫療設備行業產生了重大影響，尤其是進口診斷成像設備部件、手術用不銹鋼和塑膠耗材。醫院和診所抵制價格上漲，擠壓了製造商的淨利率。監管障礙加劇了這個問題，因為與關稅相關的供應商變更通常需要重新認證設備，從而延緩了產品上市時間。企業正透過關鍵零件的雙重採購、擴大國內同質化產品的生產以及加速研發經濟高效材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）最新發布的系列研究報告之一，涵蓋體外診斷人工智慧（AI）市場統計數據，包括全球市場規模、區域佔有率、體外診斷人工智慧（AI）市場佔有率的競爭對手、體外診斷人工智慧（AI）市場的詳細細分、市場趨勢和商業機會，以及您在體外診斷人工智慧（AI）行業取得成功所需的數據。本體外診斷人工智慧（AI）市場研究報告透過對產業現狀和未來發展趨勢的詳細分析，為您提供所需的全面觀點。

個人化醫療需求的不斷成長預計將推動人工智慧 (AI) 在體外診斷 (IVD) 領域的市場擴張。個人化醫療是指根據個人的基因譜、生活方式和環境，量身訂做預防、診斷和治療方案。個人化醫療的日益普及主要歸功於基因組數據和定序技術的進步，這些技術能夠實現更精準、更有效、更具針對性的治療。人工智慧在體外診斷領域發揮關鍵作用，它透過分析複雜的診斷數據，識別每位患者特有的疾病模式，並協助醫療服務提供者做出及時且準確的治療決策。例如，根據個人化醫療聯盟 (Personalized Medicine Coalition) 2024 年 2 月發布的報告，美國食品藥物管理局 (FDA) 在 2023 年核准了16 種針對罕見疾病的新型個人化療法，較 2022 年的 6 種顯著增加。這些療法包括 7 種癌症藥物和 3 種其他疾病藥物。因此，對個人化醫療日益成長的需求正在推動人工智慧在體外診斷領域的發展。

體外診斷人工智慧 (IVD AI) 市場的企業正致力於開發先進的解決方案，例如獲得 CE-IVDR 認證的透明人工智慧平台，以提高診斷準確性、簡化工作流程並支援個人化患者照護。獲得 CE-IVDR 認證的透明人工智慧平台是一種符合歐盟監管標準並提供清晰、審核決策的人工智慧系統。 2025 年 5 月，英國診斷檢測公司 Diagnostics.ai 推出了 PCR.AI，這是一款旨在加速和改進 PCR 診斷的先進解決方案。該平台能夠自動解讀即時PCR結果，準確率超過 99.9%，並透過清晰地展示每個結果的推導過程來提高透明度。此功能確保了符合監管要求，並增強了臨床信心。此外，它還顯著提高了實驗室效率，減少了錯誤，並支持分子診斷的無縫監管合規。

2025年4月，總部位於法國的生物梅里埃公司（bioMerieux SA）與加拿大人工智慧研究機構Mila合作，旨在推動人工智慧驅動的診斷和抗生素抗藥性檢測領域的研究與創新。該合作旨在開發尖端人工智慧解決方案，以提高體外診斷的準確性和效率，特別著重於提升抗生素抗藥性檢測能力。 Mila以其在機器學習和人工智慧研究領域的開創性工作而聞名。

體外診斷（IVD）人工智慧（AI）市場包括提供預測分析服務、遠距離診斷和病理服務、工作流程自動化和最佳化服務、數據標註以及臨床決策支援服務等服務的營業單位所獲得的收入。此市場價值還包括服務供應商銷售的或包含在其服務產品中的相關產品的價值。體外診斷（IVD）人工智慧（AI）市場還包括自動化檢測設備、人工智慧數位病理掃描儀和液態切片診斷試劑套件的銷售額。這指的是產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向終端客戶銷售的產品價值。該市場的產品價值還包括產品製造商銷售的相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球人工智慧（AI）在體外診斷（IVD）領域的應用：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球體外診斷（IVD）人工智慧（AI）市場：成長率分析
  • 全球體外診斷（IVD）人工智慧（AI）市場表現：規模與成長，2019-2024年
  • 全球體外診斷（IVD）人工智慧（AI）市場預測：規模與成長，2024-2029年，2034年預測
  • 全球體外診斷（IVD）人工智慧（AI）市場：潛在市場規模（TAM）

第6章 市場細分

  • 全球體外診斷（IVD）人工智慧（AI）市場：按組件、性能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 軟體
  • 硬體
  • 服務
  • 全球體外診斷（IVD）人工智慧（AI）市場：依技術、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 機器學習
  • 自然語言處理
  • 電腦視覺
  • 機器人和流程自動化
  • 深度學習
  • 全球體外診斷（IVD）人工智慧（AI）市場：依部署模式、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 雲端基礎的
  • 本地部署
  • 混合
  • 全球體外診斷（IVD）人工智慧（AI）市場：按應用、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 影像診斷
  • 實驗室檢查
  • 病理
  • 基因組學
  • 個人化醫療
  • 全球體外診斷（IVD）人工智慧（AI）市場依最終用戶、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 醫院和診所
  • 診斷實驗室
  • 研究所
  • 製藥公司
  • 醫療設備製造商
  • 全球體外診斷（IVD）人工智慧（AI）市場－按軟體、類型、實際值和預測值細分，2019-2024年、2024-2029年預測值、2034年預測值
  • 診斷演算法
  • 數據分析平台
  • 決策支援系統
  • 全球體外診斷（IVD）人工智慧（AI）市場－按硬體、類型、實際值和預測值細分，2019-2024年、2024-2029年預測值、2034年預測值
  • 實驗室設備
  • 影像設備
  • 即時檢測設備
  • 全球體外診斷（IVD）人工智慧（AI）市場－按服務、類型、實際值和預測值細分，2019-2024年、2024-2029年預測值、2034年預測值
  • 諮詢與實施
  • 維護和支援
  • 培訓和教育

第7章 區域和國家分析

  • 全球體外診斷（IVD）人工智慧（AI）市場按地區分類、績效及預測（2019-2024年、2024-2029年預測、2034年預測）
  • 全球體外診斷（IVD）人工智慧（AI）市場按國家分類，績效及預測（2019-2024年、2024-2029年預測、2034年預測）。

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 體外診斷（IVD）中的人工智慧（AI）：競爭格局
  • 體外診斷（IVD）市場中的人工智慧（AI）：公司概況
    • Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Illumina Inc.
  • Hologic Inc.
  • Sysmex Corporation
  • QIAGEN NV
  • Tempus Labs Inc.
  • BillionToOne Inc.
  • PathAI Inc.
  • Proscia Inc.
  • Indica Labs Inc.
  • Visiopharm A/S
  • aetherAI Co. Ltd.
  • Ibex Medical Analytics Ltd.
  • Mindpeak GmbH
  • OncoHost Ltd.
  • Qritive

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年體外診斷（IVD）人工智慧（AI）市場：提供新機會的國家
  • 2029年體外診斷（IVD）人工智慧（AI）市場：提供新機會的細分領域
  • 2029年體外診斷（IVD）人工智慧（AI）市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38426

Artificial intelligence (AI) in in vitro diagnostics (IVD) refers to the application of advanced algorithms to analyze medical data obtained from laboratory tests on samples such as blood, tissue, or urine. It enables faster, more accurate, and data-driven interpretation of test results, supporting early disease detection, personalized treatment decisions, and enhanced diagnostic efficiency.

The primary components of AI in in vitro diagnostics include software, hardware, and services. Software consists of programs and data that instruct a computer to perform specific tasks. It leverages technologies such as machine learning, natural language processing, computer vision, robotic process automation, and deep learning, and can be deployed through cloud-based, on-premise, or hybrid methods. Applications include diagnostic imaging, laboratory testing, pathology, genomics, and personalized medicine. Primary end users include hospitals and clinics, diagnostic laboratories, research institutes, pharmaceutical companies, and medical device manufacturers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The artificial intelligence (AI) in in vitro diagnostics market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in in vitro diagnostics market statistics, including artificial intelligence (AI) in the in vitro diagnostics industry's global market size, regional shares, competitors with an artificial intelligence (AI) in the in vitro diagnostics market share, detailed artificial intelligence (AI) in in vitro diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in the in vitro diagnostics industry. This artificial intelligence (AI) in vitro diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market size has grown rapidly in recent years. It will grow from $2.57 billion in 2024 to $3.04 billion in 2025 at a compound annual growth rate (CAGR) of 18.5%. Growth in the historic period was driven by a shortage of skilled healthcare professionals and radiologists, increasing government and regulatory support for AI-based diagnostics, growing application of AI in genomic and molecular diagnostics, rising awareness among clinicians of AI-enabled diagnostic accuracy, and greater availability of cloud-based AI diagnostic solutions.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market size is expected to see rapid growth in the next few years. It will grow to $5.94 billion in 2029 at a compound annual growth rate (CAGR) of 18.2%. Growth in the forecast period is expected to result from increasing demand for rapid and accurate diagnostic results, higher prevalence of chronic and infectious diseases, growing need for personalized and precision medicine approaches, stronger focus on early disease detection and prevention, and greater healthcare digitization with widespread adoption of electronic health records. Primary trends anticipated for the forecast period include advancements in deep learning for pathology and imaging, innovations in fully automated high-throughput analyzers, integration of natural language processing in diagnostic reporting, development of AI-enabled remote diagnostic platforms, and integration of AI with wearable and point-of-care devices.

The growing demand for personalized medicine is expected to drive the expansion of the artificial intelligence (AI) in in vitro diagnostics (IVD) market. Personalized medicine involves tailoring prevention, diagnosis, and treatment based on an individual's genetic profile, lifestyle, and environment. The increasing adoption of personalized medicine is largely fueled by advancements in genomic data and sequencing technologies, which allow for more precise, effective, and targeted treatments. AI in IVD plays a vital role by analyzing complex diagnostic data to identify disease patterns specific to each patient, helping healthcare providers make timely and accurate treatment decisions. For example, the Personalized Medicine Coalition reported that in February 2024, the FDA approved 16 new personalized treatments for rare diseases in 2023, a significant increase from six in 2022. This includes seven cancer drugs and three treatments for other conditions. The rising demand for personalized medicine is thus driving the growth of AI in IVD.

Companies in the AI in IVD market are focused on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms, to improve diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform is an AI system that meets EU regulatory standards, providing clear, auditable decision-making. In May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, an advanced solution designed to speed up and improve PCR diagnostics. This platform automates real-time PCR result interpretation with over 99.9% accuracy, offering transparency by clearly displaying how each result is derived. This feature ensures regulatory compliance and enhances clinical trust. It also significantly boosts laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.

In April 2025, bioMerieux SA, a France-based company specializing in AI for IVD, partnered with Mila, a Canadian AI research institute, to advance research and innovation in AI-driven diagnostics and antibiotic resistance detection. The collaboration aims to create cutting-edge AI solutions that enhance the accuracy and efficiency of IVD tools, with a particular focus on improving the detection of antibiotic resistance. Mila is renowned for its pioneering work in machine learning and AI research.

Major players in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, and Aiforia Technologies Oyj.

North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) in in vitro diagnostics (IVD) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI) in in vitro diagnostics (IVD) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market includes revenues earned by entities by providing services such as predictive analytics services, remote diagnostic and telepathology services, workflow automation, optimization services, data annotation, and clinical decision support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in in vitro diagnostics (IVD) market also includes sales of automated laboratory instruments, artificial intelligence-enabled digital pathology scanners, and liquid biopsy diagnostic kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai) in in vitro diagnostics (ivd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) in in vitro diagnostics (ivd) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) in in vitro diagnostics (ivd) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Technology: Machine Learning; Natural Language Processing; Computer Vision; Robotics Process Automation; Deep Learning
  • 3) By Deployment Model: Cloud-Based; On-Premise; Hybrid
  • 4) By Application: Diagnostic Imaging; Laboratory Testing; Pathology; Genomics; Personalized Medicine
  • 5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Pharmaceutical Companies; Medical Device Manufacturers
  • Subsegments:
  • 1) By Software: Diagnostic Algorithms; Data Analytics Platforms; Decision Support Systems
  • 2) By Hardware: Laboratory Instruments; Imaging Devices; Point-Of-Care Devices
  • 3) By Services: Consulting And Implementation; Maintenance And Support; Training And Education
  • Companies Mentioned: Roche Diagnostics GmbH; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Illumina Inc.; Hologic Inc.; Sysmex Corporation; QIAGEN N.V.; Tempus Labs Inc.; BillionToOne Inc.; PathAI Inc.; Proscia Inc.; Indica Labs Inc.; Visiopharm A/S; aetherAI Co. Ltd.; Ibex Medical Analytics Ltd.; Mindpeak GmbH; OncoHost Ltd.; Qritive; Aiforia Technologies Oyj.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Characteristics

3. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Trends And Strategies

4. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Total Addressable Market (TAM)

6. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Segmentation

  • 6.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Hardware
  • Services
  • 6.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Machine Learning
  • Natural Language Processing
  • Computer Vision
  • Robotics Process Automation
  • Deep Learning
  • 6.3. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cloud-Based
  • On-Premise
  • Hybrid
  • 6.4. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Imaging
  • Laboratory Testing
  • Pathology
  • Genomics
  • Personalized Medicine
  • 6.5. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Pharmaceutical Companies
  • Medical Device Manufacturers
  • 6.6. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Algorithms
  • Data Analytics Platforms
  • Decision Support Systems
  • 6.7. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Laboratory Instruments
  • Imaging Devices
  • Point-Of-Care Devices
  • 6.8. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting And Implementation
  • Maintenance And Support
  • Training And Education

7. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 8.1. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 9.1. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 9.2. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 10.1. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 11.1. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 11.2. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 12.1. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 13.1. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 14.1. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 14.2. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 15.1. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 15.2. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 16.1. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 17.1. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 18.1. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 19.1. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 20.1. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 21.1. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 21.2. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 22.1. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 23.1. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 23.2. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 24.1. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 24.2. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 25.1. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 25.2. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 26.1. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 26.2. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 27.1. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 28.1. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 28.2. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

  • 29.1. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview
  • 29.2. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market, Segmentation By Deployment Model, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Landscape
  • 30.2. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Company Profiles
    • 30.2.1. Roche Diagnostics GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Hologic Inc.
  • 31.3. Sysmex Corporation
  • 31.4. QIAGEN N.V.
  • 31.5. Tempus Labs Inc.
  • 31.6. BillionToOne Inc.
  • 31.7. PathAI Inc.
  • 31.8. Proscia Inc.
  • 31.9. Indica Labs Inc.
  • 31.10. Visiopharm A/S
  • 31.11. aetherAI Co. Ltd.
  • 31.12. Ibex Medical Analytics Ltd.
  • 31.13. Mindpeak GmbH
  • 31.14. OncoHost Ltd.
  • 31.15. Qritive

32. Global Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

34. Recent Developments In The Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market

35. Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer